Table 5 The count (#) and percentage (%) of errors identified and affected triples. Assessed on December 30th 2022. The remaining three metrics are not included as no quality issues are identified in these metrics. a This resource is a special case and is described in the Discussion
From: Assessing resolvability, parsability, and consistency of RDF resources: a use case in rare diseases
Resource | Non-resolvable URIs | Undefined URIs | Misused owl:ObjectProperty | |||
|---|---|---|---|---|---|---|
URIs (#/%) | affected triples (#/%) | URIs (#/%) | affected triples (#/%) | URIs (#/%) | affected triples(#/%) | |
rare-disease biobanks and registries | 5/1,068 (0.5%) | 1,039/2,085 (49.8%) | 0 | 0 | 0 | 0 |
Head and neck tumor registry Austria | 6/54 (11.1%) | 10/47 (21.3%) | 0 | 0 | 0 | 0 |
A biobank of patients with Primary Immune Deficiencies | 5/46 (10.9%) | 9/38 (23.7%) | 0 | 0 | 0 | 0 |
NeXtProt schema | 0 | 0 | 1/895 (0.1%) | 1/3,291 (0.0%) | 0 | 0 |
Orphanet catalog schema | 4/46 (8.7%) | 13/39 (33.3%) | 0 | 0 | 0 | 0 |
hPSCreg vocabulary | 95/943 (10.1%) | 105/1,000 (10.5%) | 1/943 (0.1%) | 1/1,000 (0.1%) | 0 | 0 |
Resource Metadata Ontology | 26/257 (10.1%) | 71/1,627 (4.4%) | 2/257 (0.7%) | 4/1,627 (0.2%) | 0 | 0 |
The WikiPathways Ontology | 17/124 (13.7%) | 87/149 (58.4%) | 1/19 (0.8%) | 1/149 (0.7%) | 1/19 (5.3%) | 2/149 (1.3%) |
NeXtProt vocabulary | 0 | 0 | 0 | 0 | 0 | 0 |
The UniProt ontology | 0 | 0 | 2/396 (0.5%) | 2/391 (0.5%) | 0 | 0 |
ORDO | 53/15,070 (0.3%) | 162,684/1,142,401 (14%) | 0 | 0 | 0 | 0 |
ATC | 6/6,712 (0.1%) | 14,446/66,682 (21.7%) | 0 | 0 | 0 | 0 |
HPO | 300/39,161 (0.8%) | 17,870/1,084,804 (1.6%) | 60/39,161 (0.2%) | 1,855/1,084,804 (0.2%) | 1/88 (1.1%) | 2/1,084,804 (0.0%) |
GO | 7/722 (0.9%) | 23/4,883 (0.5%) | 2/722 (0.2%) | 7/4,883 (0.1%) | 0 | 0 |
SNOMED CT a | 356,523/356,548 (99.9%) | 6,541,865/6,541,868 (99.9%) | 0 | 0 | 0 | 0 |
NCIT | 0 | 0 | 0 | 0 | 0 | 0 |